Other described resistance mechanisms in patients with CLL/SLL include chromosome 1q23 amplification and overexpression of MCL1, with associated changes to mitochondrial metabolism [139]. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.